US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
カナダ
TSXV
FP Newspapers Inc (FP) 銘柄情報

FP Newspapers Inc (FP)

0.91

0.00

(0.00%)

終了 7月5日 5:00AM

FP Newspapers Inc (FP) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.91

( - )

買値

0.88

売値

1.15

出来高

-

0.00 日の範囲 0.00

0.60 52 週間の範囲 1.20

時価総額

前日終値

0.91

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

$ 12,139

発行済株式数

6,902,592

配当利回り

PER

7.89

1 株当たり利益 (EPS)

0.12

歳入

1.79M

純利益

796k

FP Newspapers Inc. publishes, prints, and distributes daily and weekly newspapers, and specialty publications in Manitoba. The company owns and publishes the Winnipeg Free Press and Brandon Sun, and other newspapers; and is involved in printing and media businesses. It also delivers advertising mate... FP Newspapers Inc. publishes, prints, and distributes daily and weekly newspapers, and specialty publications in Manitoba. The company owns and publishes the Winnipeg Free Press and Brandon Sun, and other newspapers; and is involved in printing and media businesses. It also delivers advertising materials, as well as provides commercial printing and digital services. FP Newspapers Inc. was founded in 2002 and is based in Vancouver, Canada. 詳細を表示

セクター

Media

業界

Traditional Media

ウェブサイト

www.fpnewspapers.com

本社

Vancouver, Canada

設立

2026

FP Newspapers Inc is listed in the Media sector of the トロントベンチャー取引所 with ticker FP. The last closing price for FP Newspapers was $0.91. Over the last year, FP Newspapers shares have traded in a share price range of $ 0.60 to $ 1.20.

FP Newspapers currently has 6,902,592 shares in issue. The market capitalisation of FP Newspapers is $6.28 million. FP Newspapers has a price to earnings ratio (PE ratio) of 7.89.

FP Newspapers Inc. - Results of Annual Meeting of Shareholders

WINNIPEG, MB / ACCESS Newswire / June 3, 2026 / FP Newspapers Inc. ("FPI" or the "Corporation") announces that all resolutions...

FP Canadian Newspapers LP Announces Appointment of CAO

WINNIPEG, MB / ACCESS Newswire / February 3, 2026 / FP Canadian Newspapers Limited Partnership ("FPLP") today announced that Brent Leung...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.91	0.91	0.88	2253	0.91	CS
4	0.05	5.81395348837	0.86	0.92	0.86	4973	0.89884407	CS
12	0.21	30	0.7	0.92	0.69	5303	0.80583736	CS
26	0.21	30	0.7	1.2	0.62	10949	0.75364771	CS
52	0.28	44.4444444444	0.63	1.2	0.6	7055	0.75377554	CS
156	0.06	7.05882352941	0.85	1.2	0.43	3926	0.68277242	CS
260	-0.54	-37.2413793103	1.45	1.5	0.43	3370	0.82503255	CS

FP - Frequently Asked Questions (FAQ)

What is the current FP Newspapers Inc share price?

The current share price of FP Newspapers Inc is $ 0.91

How many FP Newspapers Inc shares are in issue?

FP Newspapers Inc has 6,902,592 shares in issue

What is the market cap of FP Newspapers Inc?

The market capitalisation of FP Newspapers Inc is CAD 6.28M

What is the 1 year trading range for FP Newspapers Inc share price?

FP Newspapers Inc has traded in the range of $ 0.60 to $ 1.20 during the past year

What is the PE ratio of FP Newspapers Inc?

The price to earnings ratio of FP Newspapers Inc is 7.89

What is the cash to sales ratio of FP Newspapers Inc?

The cash to sales ratio of FP Newspapers Inc is 3.52

What is the registered address of FP Newspapers Inc?

The registered address for FP Newspapers Inc is 733 Seymour Street, Vancouver, British Columbia, V6B 0S6

What is the FP Newspapers Inc website address?

The website address for FP Newspapers Inc is www.fpnewspapers.com

Which industry sector does FP Newspapers Inc operate in?

FP Newspapers Inc operates in the Traditional Media sector

SonicProphet49

SonicProphet49 7分前

Cryptocurrency Recovery Services: Why Acting Fast Can Make a Difference

Recovering Lost or Stolen Cryptocurrency: The Importance of Time

The cryptocurrency market continues to grow, bringing new opportunities for investors, traders, and businesses worldwide. Unfortunate

Philbot

Philbot 10分前

Valid points. Won't it get delisted by not paying its annual listing dues or annual filing statements? It probably should have been auto-delisted by now.

GoodGuyBill

GoodGuyBill 15分前

Thanks. Wish I could return the complement.

https://investorshub.advfn.com/uimage/uploads/2026/7/4/rlzkdBadpost.jpg

m0n

Imagine having a product since 2009 LoL.
Cant even pay the bills and continue to have decades upon decadesof $2.2 million in deficits. LOL
No One is Fooled

m0n

How many shareholders have passed away? I m aware of one but feel there’s more.
I FU S website has ionic studies from 2009. LoL
30 YEARS IS FASTLY APPROACHING! LoL
Same o Same o, Keep the awareness on the possibilities LoL.
No One is Fooled

barnyarddog

barnyarddog 27分前

AI Overview - Avalanche Treasury Co. (ticker: AVAT) is a Nasdaq-listed operating company that provides public market investors with direct exposure to the Avalanche blockchain ecosystem.

Rather than merely stockpiling digital assets, AVAT actively allocates capital across the Avalanc

m0n

Past 6 months WIP $150 &$130k LoL
Can’t even pay the bills without door knocking for SSI $$$ in January 2026LoL
What a Joke!
No One is Fooled

TightCoil

TightCoil 37分前

Glen Bradford - Looks Like Trump Team Simply Maximizing Frannie IPO (OTCMKTS:FNMAS)
Seeking Alpha - 17 hours ago

TechBullion
Could Pepeto Be the Best Crypto Presale to Buy as
Fannie Mae Opens the Door to Crypto Mortgages?
5 hours ago

weenphan

weenphan 45分前

https://www.otcmarkets.com/stock/CVALF/profile

Kool Aid Man

Kool Aid Man 45分前

Measly $44k left in the gas tank

40 million shares left to issue x .0011

No one goes public if they intend to self finance operations. The whole point is to print and sell shares to raise money...not to reward old bag holders who were conned by Miro years ago. Why split

jondoeuk

jondoeuk 46分前

Calling this the "gold standard" doesn't answer all the underlying concerns. This isn't a refinement of the original external-control analysis either. It uses a completely different set of external comparator trials. That means the reported survival estimate depends on which external patients are se

manibiotech

manibiotech 48分前

Yes we all know that . The previous external control arm patients were “external” , and the one’s in new PSM analysis are also different ‘external’ patients with patient level propensity matching ( so even better controls) and show even better treatment benefit . So again, what is the point you are

Naught

Naught 49分前

Should we expect some notices from. PAC in the very near term then...?

weenphan

weenphan 49分前

I posted on the PCHM board for over a decade. I bought PCHM as low as .0013 and sold stock as high as $5 plus. It was a once in a lifetime percentage gainer. My aliases were LMLYP, Rosesarefree and GeneandDean, which all are references to a band Ween. I'm weenphan on this board.

newflow

newflow 50分前

Ron, Dissolved vs Extinct
No Altaba distributed immediately before dissolution, can you find any company distributing value to equity holders after its complete dissolution long-form or regular Dissolution.
Gemini's Response:
It is important to clarify a key point about Delaware

DA88

Can someone explain who this guy is and why his perspective matters? Love that he is positive, but he doesn’t look like he is anything more than a shareholder.

PickStocks

PickStocks 53分前

Yes….but we do not have anything to do with Paladin. So it means nothing which is easily verified by a simple phone call….

jondoeuk

jondoeuk 57分前

Whether this particular analysis has been submitted is something nobody outside NWBO and the MHRA knows.

jondoeuk

jondoeuk 59分前

This is not simply a refinement of the published JAMA Oncology analysis. It's a different external-control analysis built from a different pool of comparator trials. The fact they constructed a propensity-score matched analysis using individual patient data from AVAGLIO, CENTRIC, and CORE, means the

ihorchu

ihorchu 1時間前

A fantastic day to remember! Since no humidity here, heat is very tolerable.

jondoeuk

jondoeuk 1時間前

'While encouraging, our clinical findings must be interpreted with caution. Even though this was a randomized clinical trial (randomization software assigned patients to TLR agonist/placebo groups), the small number of patients enrolled contributed to an imbalance in patient selection between the tr

kevindenver

kevindenver 1時間前

Nowhere in the interview was "Blarcamesine" mentioned. There was a snippet towards the end where autophagy is mentioned.

Maybe you hallucinated that this interview was related to blarcamesine?

A transcript of the interview can be found here:
https://podcasts.hap

TightCoil

TightCoil 1時間前

Yes, next week is the week we FLY

Supersearch Plus

Greenkraft (PK)

Fiserv Inc Dl 01

T Rowe Price Growth ETF

Scout24 SE NA ON

TELUS International Cda

Amundi MSCI World Minimu...

Xtrackers II JP Morgan E...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。